News
This could inform the development of new therapies. When the molecular machinery in our cells gets to work transcribing the ...
NIH director Jay Bhattacharya has offered a new explanation for why the federal government canceled $500 million in contracts ...
NIH Director Jay Bhattacharya offered an explanation for the cancellation of mRNA vaccine contracts that didn't align with ...
The U.S. Food and Drug Administration (FDA) is unlikely to renew the authorization granted to use Pfizer (NYSE:PFE) and BioNTech’s (BNTX) COVID-19 vaccine in young children this fall, The Guardian ...
Known as promoter-proximal pausing, this interruption in the transcription activity of RNA polymerase II—the enzyme ...
21h
Dealbreaker on MSNBioNTech to Pay $740M-Plus to Settle mRNA Patent Disputes, Smooth $1.25 Billion DealAfter BioNTech’s acquisition of CureVac closes, BioNTech will pay GSK another $130 million and a 1% royalty on rest-of-world ...
The mRNA Therapeutics market is expanding due to advancements in drug development, personalized medicine, and delivery technologies. Opportunities arise from the technology's success in vaccines and ...
Trump administration has unwisely cancelled mRNA vaccine research while doing little about Americans’ unhealthy diet.
The move drew sharp criticism from medical and health experts. “Scrapping the fastest platform we have is a reckless move ...
The fundraise will help advance a cancer therapy that’s already shown early promise in people whose cancers haven’t responded ...
New messenger RNA vaccines to fight the coronavirus are based on a technology that could transform medicine. Next up: sickle cell and HIV. On December 23, as part of a publicity push to encourage ...
President Trump’s laissez-faire approach is notable, given that the development of the Covid vaccine was seen as one of his ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results